CAS RN: 1022915-33-8
[1,4]Oxazepan-6-ol
Product Availability
Choose a grade to view its available package options.
5 package records 4 with current stock 1 grade group
Grade
96% (5)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250531
100mg
In stock
Shanghai, Tianjin Inquiry
Batchno.20250911
1g
In stock
Shenzhen Inquiry
Batchno.20250413
250mg
In stock
Shanghai, Tianjin, Chengdu Inquiry
Batchno.20250715
50mg
In stock
Shanghai, Tianjin Inquiry
Batchno.20260211
50mg / 100mg / 250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1022915-33-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
1022915-33-8 / (6R)-1,4-oxazepan-6-ol
1,4-oxazepan-6-ol | [1,4]Oxazepan-6-ol | MFCD22201128
Standard CAS: 1022915-33-8
Multi CAS: Yes
Basic Information
copy
CAS
1022915-33-8 copy
Multi CAS
Yes copy
Molecular Formula
C5H11NO2 copy
Molecular Weight
117.150000 copy
Exact Mass
117.078979 copy
SMILES
C1COC[C@@H](CN1)O copy
InChI
InChI=1S/C5H11NO2/c7-5-3-6-1-2-8-4-5/h5-7H,1-4H2/t5-/m1/s1 copy
InChIKey
AJQUDIYIICBQDR-RXMQYKEDSA-N copy
Synonyms
1,4-oxazepan-6-ol
[1,4]Oxazepan-6-ol
MFCD22201128
(R)-[1,4]Oxazepan-6-ol
SCHEMBL10051752 copy
Computed Properties
copy
Structural Parameters
Heavy atom count
8 copy
Fraction Csp3
1 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
29.7 copy
TPSA
41.49 copy
LogP / Solubility
WLOGP
-1.03 copy
MLOGP
-0.92 copy
XLogP3
-1.2 copy
Consensus LogP
-1.05 copy
Log S (ESOL)
0.08 copy
Class (ESOL)
Highly soluble copy
Log S (Ali)
0.23 copy
Class (Ali)
Highly soluble copy
Log S (SILICOS-IT)
0.44 copy
Class (SILICOS-IT)
Highly soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.17 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy